We next tested whether IMPDH2 inhibitors (RIB, MPA) impact SARS-CoV-2 infection in vitro, considering that virus-mediated NF-κB activation modulates viral infection (39–42). The gene discussed is NFKB1; the disease is viral infectious disease.